Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Biological effects of rAAV-caAlk2 coating on structural allograft healing.

Koefoed M, Ito H, Gromov K, Reynolds DG, Awad HA, Rubery PT, Ulrich-Vinther M, Soballe K, Guldberg RE, Lin AS, O'Keefe RJ, Zhang X, Schwarz EM.

Mol Ther. 2005 Aug;12(2):212-8.

3.

Recent advances in gene delivery for structural bone allografts.

Awad HA, Zhang X, Reynolds DG, Guldberg RE, O'Keefe RJ, Schwarz EM.

Tissue Eng. 2007 Aug;13(8):1973-85. Review.

PMID:
17518728
4.

Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, Nakamura T, Soballe K, O'Keefe RJ, Boyce BF, Schwarz EM.

Nat Med. 2005 Mar;11(3):291-7. Epub 2005 Feb 13.

5.

Adeno-associated virus-coated allografts: a novel approach for cranioplasty.

Ben Arav A, Pelled G, Zilberman Y, Kimelman-Bleich N, Gazit Z, Schwarz EM, Gazit D.

J Tissue Eng Regen Med. 2012 Nov;6(10):e43-50. doi: 10.1002/term.1594. Epub 2012 Sep 3.

6.

The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings.

Yazici C, Yanoso L, Xie C, Reynolds DG, Samulski RJ, Samulski J, Yannariello-Brown J, Gertzman AA, Zhang X, Awad HA, Schwarz EM.

Biomaterials. 2008 Oct;29(28):3882-7. doi: 10.1016/j.biomaterials.2008.06.007. Epub 2008 Jun 30.

7.

Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.

Galeano M, Deodato B, Altavilla D, Squadrito G, Seminara P, Marini H, Stagno d'Alcontres F, Colonna M, Calò M, Lo Cascio P, Torre V, Giacca M, Venuti FS, Squadrito F.

Crit Care Med. 2003 Apr;31(4):1017-25.

PMID:
12682466
8.

Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.

Basile P, Dadali T, Jacobson J, Hasslund S, Ulrich-Vinther M, Søballe K, Nishio Y, Drissi MH, Langstein HN, Mitten DJ, O'Keefe RJ, Schwarz EM, Awad HA.

Mol Ther. 2008 Mar;16(3):466-73. doi: 10.1038/sj.mt.6300395. Epub 2008 Jan 8.

9.

Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.

Ulrich-Vinther M, Carmody EE, Goater JJ, S balle K, O'Keefe RJ, Schwarz EM.

J Bone Joint Surg Am. 2002 Aug;84-A(8):1405-12.

PMID:
12177271
10.

Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur.

Yazici C, Takahata M, Reynolds DG, Xie C, Samulski RJ, Samulski J, Beecham EJ, Gertzman AA, Spilker M, Zhang X, O'Keefe RJ, Awad HA, Schwarz EM.

Mol Ther. 2011 Aug;19(8):1416-25. doi: 10.1038/mt.2010.294. Epub 2011 Jan 4.

11.

Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering.

Xie C, Reynolds D, Awad H, Rubery PT, Pelled G, Gazit D, Guldberg RE, Schwarz EM, O'Keefe RJ, Zhang X.

Tissue Eng. 2007 Mar;13(3):435-45.

PMID:
17518596
12.

Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse.

Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F.

Diabetologia. 2003 Apr;46(4):546-55. Epub 2003 Apr 2.

PMID:
12677400
13.

Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.

Sarukhan A, Soudais C, Danos O, Jooss K.

J Gene Med. 2001 May-Jun;3(3):260-70.

PMID:
11437331
14.

Use of recombinant adeno-associated viral vectors as a tool for labeling bone marrow cells.

Iwakura A, Dean J, Hamada H, Eaton E, Qin G, Losordo DW, Aikawa R.

J Mol Cell Cardiol. 2005 May;38(5):799-802.

PMID:
15850573
15.

Enhancing allograft bone healing through gene therapy.

Rubery PT.

Spine (Phila Pa 1976). 2010 Aug 1;35(17):1640-7. doi: 10.1097/BRS.0b013e3181ccc7bf. Review.

PMID:
20628339
16.

Dual growth factor delivery from biofunctionalized allografts: Sequential VEGF and BMP-2 release to stimulate allograft remodeling.

Sharmin F, McDermott C, Lieberman J, Sanjay A, Khan Y.

J Orthop Res. 2017 May;35(5):1086-1095. doi: 10.1002/jor.23287. Epub 2017 Mar 23.

PMID:
27155087
17.

Targeting of ALK2, a Receptor for Bone Morphogenetic Proteins, Using the Cre/lox System to Enhance Osseous Regeneration by Adipose-Derived Stem Cells.

Peterson JR, Eboda O, Agarwal S, Ranganathan K, Buchman SR, Lee M, Wang SC, Mishina Y, Levi B.

Stem Cells Transl Med. 2014 Nov;3(11):1375-80. doi: 10.5966/sctm.2014-0082. Epub 2014 Sep 17.

18.
19.

Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium.

Tsai ML, Chen SL, Chou PI, Wen LY, Tsai RJ, Tsao YP.

Invest Ophthalmol Vis Sci. 2002 Mar;43(3):751-7.

PMID:
11867594
20.

Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo.

Zhang C, Wang KZ, Qiang H, Tang YL, Li Q, Li M, Dang XQ.

Acta Pharmacol Sin. 2010 Jul;31(7):821-30. doi: 10.1038/aps.2010.67. Epub 2010 Jun 28.

Supplemental Content

Support Center